House Antidepressant Hearing Rescheduled For Sept. 9
This article was originally published in The Pink Sheet Daily
Executive Summary
The hearing was postponed from July 20 when former subcommittee Chairman Greenwood accepted a position as BIO president. Witnesses could include seven antidepressant manufacturers.